EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Decellularized materials derived from TSP2-KO mice promote enhanced neovascularization and integration in diabetic wounds



Decellularized materials derived from TSP2-KO mice promote enhanced neovascularization and integration in diabetic wounds



Biomaterials 169: 61-71



Decellularized biologic scaffolds are gaining popularity over synthetic biomaterials as naturally derived materials capable of promoting improved healing. Nevertheless, the most widely used biologic material - acellular dermal matrix (ADM) - exhibits slow repopulation and remodeling, which prevents integration. Additionally, engineering control of these materials is limited because they require a natural source for their production. In the current report, we demonstrate the feasibility of using genetically engineered animals to create decellularized biologic scaffolds with favorable extracellular matrix (ECM) properties. Specifically, we utilized skin from thrombospondin (TSP)-2 KO mice to derive various decellularized products. Scanning electron microscopy and mechanical testing showed that TSP-2 KO ADM exhibited an altered structure and a reduction in elastic modulus and ultimate tensile strength, respectively. When a powdered form of KO ADM was implanted subcutaneously, it was able to promote enhanced vascularization over WT. Additionally, when implanted subcutaneously, intact slabs of KO ADM were populated by higher number of host cells when compared to WT. In vitro studies confirmed the promigratory properties of KO ADM. Specifically, degradation products released by pepsin digestion of KO ADM induced greater cell migration than WT. Moreover, cell-derived ECM from TSP-2 null fibroblasts was more permissive to fibroblast migration. Finally, ADMs were implanted in a diabetic wound model to examine their ability to accelerate wound healing. KO ADM exhibited enhanced remodeling and vascular maturation, indicative of efficient integration. Overall, we demonstrate that genetic manipulation enables engineered ECM-based materials with increased regenerative potential.

(PDF emailed within 0-6 h: $19.90)

Accession: 057524452

Download citation: RISBibTeXText

PMID: 29631168

DOI: 10.1016/j.biomaterials.2018.03.049



Related references

Decellularized materials derived from TSP2-KO mice promote enhanced neovascularization and integration in diabetic wounds. Biomaterials 169: 61-71, 2018

Lack of uptake of TSP2 by megakaryocytes in TSP2-null mice A potential explanation for the bleeding diathesis and platelet abnormality. Blood 96(11 Part 1): 815a, November 16, 2000

Exosomes derived from platelet-rich plasma promote the re-epithelization of chronic cutaneous wounds via activation of YAP in a diabetic rat model. Theranostics 7(1): 81-96, 2017

Enhanced healing of diabetic wounds by topical administration of adipose tissue-derived stromal cells overexpressing stromal-derived factor-1: biodistribution and engraftment analysis by bioluminescent imaging. Stem Cells International 2011: 304562-304562, 2011

Enhanced healing of diabetic wounds by subcutaneous administration of human umbilical cord derived stem cells and their conditioned media. International Journal of Endocrinology 2013: 592454-592454, 2013

Differentiated osteoblasts derived decellularized extracellular matrix to promote osteogenic differentiation. Biomaterials Research 22: 4-4, 2018

Skin-derived precursor cells promote wound healing in diabetic mice. Annals of Plastic Surgery 74(1): 114-120, 2015

Peritoneal cavity is a route for gut-derived microbial signals to promote autoimmunity in non-obese diabetic mice. Scandinavian Journal of Immunology 81(2): 102-109, 2015

Combined effects of PLGA and vascular endothelial growth factor promote the healing of non-diabetic and diabetic wounds. Nanomedicine 11(8): 1975-1984, 2016

Enhanced epithelial gap closure and increased angiogenesis in wounds of diabetic mice treated with adult murine bone marrow stromal progenitor cells. Wound Repair and Regeneration 15(3): 350-359, 2007

The chemokine stromal cell-derived factor-1╬▒ promotes endothelial progenitor cell-mediated neovascularization of human transplanted fat tissue in diabetic immunocompromised mice. Plastic and Reconstructive Surgery 132(2): 239e-250e, 2013

Use of topical sRAGE in diabetic wounds increases neovascularization and granulation tissue formation. Annals of Plastic Surgery 52(5): 519-21; Discussion 522, 2004

Angiopoietin-1 improves endothelial progenitor cell-dependent neovascularization in diabetic wounds. Surgery 158(3): 846-856, 2015

Mesenchymal stem cells promote cardiac muscle repair via enhanced neovascularization. Cellular Physiology and Biochemistry 35(3): 1219-1229, 2015

Enhanced function of electrofusion-derived surrogate B-cells implanted in diabetic nude mice. Diabetologia 41(SUPPL 1): A131, 1998